Krintafel

Product manufactured by Glaxosmithkline Llc

Application Nr Approved Date Route Status External Links
NDA210795 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Krintafel Is Indicated For The Radical Cure (Prevention Of Relapse) Of Plasmodium Vivax Malaria In Patients Aged 16 Years And Older Who Are Receiving Appropriate Antimalarial Therapy For Acute P. Vivax Infection [See Dosage And Administration ( 2.2 )] . Limitation Of Use Krintafel Is Not Indicated For The Treatment Of Acute P. Vivax Malaria. Krintafel Is An Antimalarial Indicated For The Radical Cure (Prevention Of Relapse) Of Plasmodium Vivax Malaria In Patients Aged 16 Years And Older Who Are Receiving Appropriate Antimalarial Therapy For Acute P. Vivax Infection. ( 1 ) Limitation Of Use Krintafel Is Not Indicated For The Treatment Of Acute P. Vivax Malaria. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Tafenoquine Succinate TAFENOQUINE SUCCINATE ZINC1888486

Comments